Performance II Study

 

About

The purpose of this pilot study is to assess whether a lower blood pressure (e.g., <120mmHg) versus usual care is acceptable for adolescents and young adults, and to examine biomarkers of inflammation and organ perfusion during intensive blood pressure lowering. 

Eligibility

  • between the ages of 13-40
  • taking at least one anti-hypertensive agent or have an office SBP ≥120 mmHg
  • have a kidney transplant

If you are a UCSF patient and are interested in participating, please contact us at [email protected]